The investigation of CD4+ T cell clones from cerebral spinal fluid (CSF) of patients with MS (a Th1-mediated disease) and control subjects showed that TIM-3 expression was down-regulated in MS [25]. This evidence concerns the gene CD4 and myeloid sarcoma.